DEVELOPMENT AND IN-VITRO EVALUATION OF CHITOSAN-BASED TRANSDERMAL DRUG-DELIVERY SYSTEMS FOR THE CONTROLLED DELIVERY OF PROPRANOLOL HYDROCHLORIDE

被引:103
作者
THACHARODI, D [1 ]
RAO, KP [1 ]
机构
[1] CENT LEATHER RES INST,DIV BIOMAT,MADRAS 600020,TAMIL NADU,INDIA
关键词
TRANSDERMAL DRUG DELIVERY; CHITOSAN; CROSS-LINKING; PROPRANOLOL HYDROCHLORIDE;
D O I
10.1016/0142-9612(95)98278-M
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Membrane permeation-controlled transdermal drug delivery systems were prepared using the natural polymer, chitosan. An adhesive sealing technique was used to construct the devices. Propranolol hydrochloride was selected as the model drug for the present study. Chitosan membranes with different permeability to propranolol hydrochloride obtained by controlled cross-linking with glutaraldehyde were used to regulate the drug release in the devices. Chitosan gel was used as the drug reservoir. The ability of these devices to deliver the drug while supported on rabbit pinna skin was tested by conducting in vitro studies in modified Franz diffusion cells. The drug release profiles showed that the drug delivery is completely controlled by the devices. The rate of drug release was found to be dependent on the type of membrane used.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 15 条
[1]   STUDIES ON THE CARBOXYMETHYL CHITOSAN-CONTAINING LIPOSOMES FOR THEIR STABILITY AND CONTROLLED RELEASE OF DAPSONE [J].
ALAMELU, S ;
RAO, KP .
JOURNAL OF MICROENCAPSULATION, 1991, 8 (04) :505-519
[2]   CHITOSAN MATRIX FOR ORAL SUSTAINED DELIVERY OF AMPICILLIN [J].
CHANDY, T ;
SHARMA, CP .
BIOMATERIALS, 1993, 14 (12) :939-944
[3]  
Chien Y. W., 1987, TRANSDERMAL CONTROLL
[4]  
DEMEY C, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1508
[5]   OPTIMIZED FORMULATION OF MAGNETIC CHITOSAN MICROSPHERES CONTAINING THE ANTICANCER AGENT, OXANTRAZOLE [J].
HASSAN, EE ;
PARISH, RC ;
GALLO, JM .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :390-397
[6]   CONTROLLED RELEASE OF RIBOFLAVIN AND INSULIN THROUGH CROSS-LINKED POLY(VINYL ALCOHOL) CHITOSAN BLEND MEMBRANE [J].
KIM, JH ;
KIM, JY ;
LEE, YM ;
KIM, KY .
JOURNAL OF APPLIED POLYMER SCIENCE, 1992, 44 (10) :1823-1828
[7]  
KURIHARABERGSTR.T, 1991, J CONTROL RELEASE, V15, P271
[8]   CONTACT-DERMATITIS TO TRANSDERMAL ESTRADIOL SYSTEM [J].
MCBURNEY, EI ;
NOEL, SB ;
COLLINS, JH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (03) :508-510
[9]   BIOLOGICAL-ACTIVITY OF CHITOSAN - ULTRASTRUCTURAL-STUDY [J].
MUZZARELLI, R ;
BALDASSARRE, V ;
CONTI, F ;
FERRARA, P ;
BIAGINI, G ;
GAZZANELLI, G ;
VASI, V .
BIOMATERIALS, 1988, 9 (03) :247-252
[10]   OSTEOCONDUCTION EXERTED BY METHYLPYRROLIDINONE CHITOSAN USED IN DENTAL SURGERY [J].
MUZZARELLI, RAA ;
BIAGINI, G ;
BELLARDINI, M ;
SIMONELLI, L ;
CASTALDINI, C ;
FRATTO, G .
BIOMATERIALS, 1993, 14 (01) :39-43